Processing your payment...
Please do not close your browser.

Veterinary Pain Management Drugs Market- Global Growth, Trends and Forecast (2022 - 2029) By Types (Companion,Livestock) , By Application (Osteoarthritis and Joint Pain, Postoperative Pain,Cancer) By Regions

24 Jun, 2022 | 164 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the Forecast Year Veterinary Pain Management Drugs market will register a CAGR of 6.8%  in terms of revenue and the global market size will reach USD 1.87 Billion by 2029

Veterinary Pain Management Drugs Market Overview

Veterinary pain management is a critical component of veterinary medicine. Animals experience pain, which can be chronic, but are unable to articulate it. Surgical discomfort, arthritis, and cancer have all been linked to pain in animals. Chronic discomfort in animals is frequently referred to as "growing old" or "slowing down." This could affect both farm and pet animal output, as well as their temperament. The availability of different treatments to treat the varied causes of pain in animals, including pain medications, physical rehabilitation, acupuncture, laser therapy, and therapeutic massage, to name a few, is a result of ongoing research on reducing chronic pain in animals. Reluctance to walk on slick surfaces, many trips up and down the stairs, and selective urination are all symptoms that your pet is in pain.

Veterinary pain management refers to the use of various medications and pharmacological combinations to relieve chronic pain in animals. It entails watching for behavioural indicators and predicting the kind, severity, and duration of pain. Physical compresses, massages, therapy, rehabilitation, acupuncture, laser therapy, and the prescription of therapeutic and antianxiety medicines are all part of the treatment. These medications can be taken orally, parenterally, or topically. Changes in housing, nutrition, and level of interaction with other animals and humans are all part of veterinary pain management. It is helpful against acute surgical, traumatic, and disease-related pain, as well as aiding in the improvement of the animal's overall health.

Growing adoption of companion animals, rising numbers of veterinary practitioners and their rising income levels in developed economies, rising prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with rising animal health are all factors driving market growth.

What is our Veterinary Pain Management Drugs Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 6.8% during the review period (2022 to 2029).

 

By Type

  • Companion
  • Livestock

 

By Application

  • Osteoarthritis and Joint Pain
  • Postoperative Pain
  • Cancer
  • Others

 

 By Companies

 

 

 

  • Assisi Animal Health
  • Bayer AG
  • Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
  • Ceva Sante Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals PLC
  • Eli Lilly
  • Company
  • Idexx Laboratories Inc.
  • Merck & Co. Inc.
  • Norbrook
  • Vetoquinol S.A.
  • Zoetis Inc.

 

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2016-2021

Forecast Year

 

2022 to 2029

Number of Pages

164

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Veterinary Pain Management Drugs Market?

The Veterinary Pain Management Drugs Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The  gross margin, the prices they charge. The main players in this market: Assisi Animal Health, Bayer AG, Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG), Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eli Lilly, Company, Idexx, aboratories Inc., Merck & Co. Inc., Norbrook, Vetoquinol S.A., Zoetis Incand Other.

Industry News

Chanelle Pharma announced as new sponsor of the Irish Champion Hurdle

Chanelle Pharma is delighted to announce it is the new sponsor of the Irish Champion Hurdle at Leopardstown's Dublin Racing Fesitival.

What are the major Applications, Types of the Oral Veterinary Pain Management Drugs Market?

By Type, it is segmented into

  • Companion
  • Livestock

By Applications, it is segmented into

  • Osteoarthritis and Joint Pain
  • Postoperative Pain
  • Cancer
  • Others

Veterinary Pain Management Drugs Market Regional Analysis

The market share of medicines from the United States and other foreign countries, including local manufacturing by foreign companies and foreign-owned compounds leased to Japanese companies, is projected to be significantly greater. According to IQVIA, one of the world's largest contract research organizations, and foreign companies, Japan's overall growth will be the slowest among developed markets in 2022-2029, with a compound annual growth rate (CAGR) between 2% and 1%, while global growth is expected to be between 3 percent and 6 percent.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

 

  1. INTRODUCTION
    • MARKET DEFINITION
    • MARKET DYNAMICS
    • MARKET SEGMENTATION
    • REPORT TIMELINES
    • KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    • DATA MINING
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • SUBJECT MATTER EXPERT ADVICE
    • QUALITY CHECK
    • FINAL REVIEW
      • DATA TRIANGULATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
    • GLOBAL VETERINARY PAIN MANAGEMENT DRUGS TREATMENT BY TYPES
    • GLOBAL VETERINARY PAIN MANAGEMENT DRUGS BY APPLICATIONS
  4. MARKET DYNAMICS
    • DRIVERS
      • INCREASING DEMAND FOR VETERINARY PAIN MANAGEMENT DRUGS RESTRAINTS
      • STRINGENT ENVIRONMENTAL REGULATIONS
      • HIGH COST ON MATERIALS
    • OPPORTUNITIES
      • VETERINARY PAIN MANAGEMENT DRUGS GROWTH
      • APPLICATION OF VETERINARY PAIN MANAGEMENT DRUGS
      • IMPACT OF COVID 19
  5. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPES
    • INTRODUCTION
    • COMPANION
    • LIVESTOCK
    • OTHERS
  6. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY APPLICATION
    • INTRODUCTION
    • OSTEOARTHRITIS AND JOINT PAIN
    • POSTOPERATIVE PAIN
    • CANCER
    • OTHERS
  7. GLOBAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY REGION
    • NORTH AMERICA
      • US
      • CANADA
      • MEXICO
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • APAC
      • CHINA
      • SOUTH KOREA
      • JAPAN
      • INDIA
      • AUSTRALIA
      • ASEAN
      • REST OF APAC
    • MIDDLE EAST AND  AFRICA
      • SAUDI ARABIA
      • UAE
      • SOUTH AFRICA
      • TURKEY
      • REST OF MEA
    • SOUTH AMERICA
      • BRAZIL
      • REST OF MEA
      • ARGENTINA
      • REST OF SOUTH AMERICA
  8. COMPETITIVE LANDSCAPE
    • MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    • AND AGREEMENTS
      • KEY DEVELOPMENT
    • MARKET SHARE PERCENTAGE RANKING ANALYSIS
    • STRATEGIES ADOPTED BY LEADING PLAYERS
  9. COMPANY PROFILES
    • BUSINESS OVERVIEW
    • COMPANY SNAPSHOT
    • PRODUCT BENCHMARKING
    • STRATEGIC INITIATIVES
  1. ASSISI ANIMAL HEALTH
  2. BAYER AG
  3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH (C. H. BOEHRINGER SOHN AG & CO. KG)
  4. CEVA SANTE ANIMALE
  5. CHANELLE PHARMA
  6. DECHRA PHARMACEUTICALS PLC
  7. ELI LILLY
  8. COMPANY
  9. IDEXX LABORATORIES INC.
  10. MERCK & CO. INC.
  11. NORBROOK
  12. VETOQUINOL S.A.
  13. ZOETIS INC.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla